1. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice
- Author
-
Lola, Weiss, Steve, Bernstein, Richard, Jones, Ravi, Amunugama, David, Krizman, Lellean, Jebailey, Osnat, Almogi-Hazan, Osnat, Hazan, Zhanna, Yekhtin, Janna, Yachtin, Reut, Shiner, Israel, Reibstein, Elizabeth, Triche, Shimon, Slavin, Reuven, Or, and Eytan R, Barnea
- Subjects
Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Apoptosis ,Islets of Langerhans ,Mice ,Endocrinology ,Mice, Inbred NOD ,Internal medicine ,Diabetes mellitus ,medicine ,Animals ,Insulin ,Pancreas ,NOD mice ,Drug Implants ,Type 1 diabetes ,Glucose tolerance test ,Dose-Response Relationship, Drug ,biology ,medicine.diagnostic_test ,Pancreatic islets ,medicine.disease ,Disease Models, Animal ,Oxidative Stress ,Insulin receptor ,Diabetes Mellitus, Type 1 ,Glucose ,medicine.anatomical_structure ,biology.protein ,Cytokines ,Female ,Peptides - Abstract
Preimplantation factor (PIF) is a novel embryo-secreted immunomodulatory peptide. Its synthetic analog (sPIF) modulates maternal immunity without suppression. There is an urgent need to develop agents that could prevent the development of type 1 diabetes mellitus (TIDM). Herein, we examine sPIF’s preventive effect on TIDM development by using acute adoptive-transfer (ATDM) and spontaneously developing (SDM) in non-obese diabetic (NOD) murine models. Diabetes was evaluated by urinary and plasma glucose, intraperitoneal glucose tolerance test (IPGTT), pancreatic islets insulin staining by immunohistochemistry and by pancreatic proteome evaluation using mass spectrometry, followed by signal pathway analysis. Continuous administration of sPIF for 4-weeks prevents diabetes development in ATDM model in >90% of recipients demonstrated by normal IPGTT, preserved islets architecture, number, and insulin staining. (P
- Published
- 2011